J Korean Rheum Assoc.  2000 Dec;7(4):381-389.

Bacteremia in Patients with Systemic Lupus Erythematosus

Affiliations
  • 1Department of Internal Medicine, College of Medicine, The Catholic University of Korea.

Abstract


OBJECTIVE
To determine the causative organisms and predisposing factors of bacteremia in patients with systemic lupus erythemaosus (SLE).
METHODS
We retrospectively evaluated medical records of 358 patients with SLE who were followed in Kangnam St. Mary? Hospital from 1992 to 1997. Bacteremic SLE patients were compared to non-bacteremic SLE patients in terms of laboratory and clinical variables.
RESULTS
Twenty-nine episodes of bacteremia in 27 patients with SLE (26 women, 1 man) were identified. The episode of community acquired bacteremia (n=21, 72.4%) was more frequent than that of hospital acquired bacteremia (n=8, 27.6%). Isolated bacterial organisms from blood were as follows: gram negative organisms (n=14); Salmonella species (n=8), E. coli (n=4), P. mirabilis (n=1), K. pneumonia (n=1). gram positive organisms (n=15); S. aureus (n=6), Streptococcus pneumoniae (n=2), coagulase negative Staphylococci (n=2), Bacillus species (n=1), Streptococcus viridans (n=1), Streptococcus pyogenes (n=1), Enterococcus faecalis (n=1), Listeria monocytogenes (n=1). SLE was the most common underlying condition among Salmonella bacteremic patients. One of twenty seven bacteremic SLE patients (3.8%) died in spite of antibiotic therapy. Logistic regression analysis of the laboratory and clinical variables between bacteremic SLE patients and non-bacteremic SLE patients (n=140) showed that bacteremic SLE patients were more frequently associated with thrombocytopenia (p=0.008, odds ratio (OR)=7.8, 95% confidence interval (CI), 1.7 to 35.9), lupus nephritis (p=0.023, OR=5.3, 95% CI, 1.1 to 26.8), and high dose steroid therapy (prednisolone > 0.5mg/kg/day, p=0.008, OR=12.1, 95% CI 2.5 to 58.6) than non-bacteremic SLE patients.
CONCLUSION
Our data suggested that Salmonella was the single most frequent isolate from the blood of SLE patients. Lupus nephritis and high dose steroid therapy were independent predisposing factors for the development of bacteremia in SLE patients.

Keyword

Systemic lupus erythematosus; Bacteremia

MeSH Terms

Bacillus
Bacteremia*
Causality
Coagulase
Enterococcus faecalis
Female
Humans
Listeria monocytogenes
Logistic Models
Lupus Erythematosus, Systemic*
Lupus Nephritis
Medical Records
Mirabilis
Odds Ratio
Pneumonia
Retrospective Studies
Salmonella
Streptococcus pneumoniae
Streptococcus pyogenes
Thrombocytopenia
Viridans Streptococci
Coagulase
Full Text Links
  • JKRA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr